Rockefeller Capital Management L.P. Raises Stock Holdings in HCA Healthcare, Inc. $HCA

Rockefeller Capital Management L.P. boosted its position in HCA Healthcare, Inc. (NYSE:HCA) by 17.9% in the fourth quarter, HoldingsChannel.com reports. The firm owned 18,957 shares of the company’s stock after acquiring an additional 2,876 shares during the period. Rockefeller Capital Management L.P.’s holdings in HCA Healthcare were worth $8,850,000 as of its most recent SEC filing.

Several other large investors have also recently modified their holdings of the company. Sumitomo Life Insurance Co. lifted its holdings in shares of HCA Healthcare by 1.0% during the 4th quarter. Sumitomo Life Insurance Co. now owns 2,026 shares of the company’s stock valued at $946,000 after purchasing an additional 20 shares during the last quarter. MJP Associates Inc. ADV increased its position in HCA Healthcare by 2.9% during the 4th quarter. MJP Associates Inc. ADV now owns 749 shares of the company’s stock valued at $350,000 after buying an additional 21 shares in the last quarter. Cary Street Partners Investment Advisory LLC boosted its holdings in HCA Healthcare by 7.5% in the fourth quarter. Cary Street Partners Investment Advisory LLC now owns 300 shares of the company’s stock worth $140,000 after acquiring an additional 21 shares in the last quarter. Cary Street Partners Financial LLC boosted its stake in HCA Healthcare by 3.9% in the 3rd quarter. Cary Street Partners Financial LLC now owns 590 shares of the company’s stock worth $251,000 after purchasing an additional 22 shares in the last quarter. Finally, Plato Investment Management Ltd lifted its stake in shares of HCA Healthcare by 0.6% during the fourth quarter. Plato Investment Management Ltd now owns 3,908 shares of the company’s stock worth $1,833,000 after buying an additional 22 shares during the period. Institutional investors own 62.73% of the company’s stock.

HCA Healthcare Stock Down 0.2%

Shares of NYSE HCA opened at $387.14 on Friday. HCA Healthcare, Inc. has a 52-week low of $330.00 and a 52-week high of $556.52. The company’s 50-day simple moving average is $410.50 and its 200-day simple moving average is $465.84. The firm has a market cap of $85.88 billion, a price-to-earnings ratio of 13.31, a price-to-earnings-growth ratio of 1.23 and a beta of 1.12.

HCA Healthcare (NYSE:HCA) last issued its quarterly earnings results on Friday, April 24th. The company reported $7.15 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $7.19 by ($0.04). HCA Healthcare had a negative return on equity of 295.93% and a net margin of 8.89%.The firm had revenue of $19.11 billion during the quarter, compared to analyst estimates of $19.09 billion. During the same period in the prior year, the firm earned $6.45 earnings per share. The business’s revenue was up 4.3% on a year-over-year basis. HCA Healthcare has set its FY 2026 guidance at 29.100-31.500 EPS. Equities research analysts anticipate that HCA Healthcare, Inc. will post 30.07 EPS for the current fiscal year.

HCA Healthcare Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, June 30th. Investors of record on Tuesday, June 16th will be given a $0.78 dividend. This represents a $3.12 annualized dividend and a yield of 0.8%. The ex-dividend date is Tuesday, June 16th. HCA Healthcare’s dividend payout ratio is presently 10.73%.

Analysts Set New Price Targets

A number of research analysts have recently weighed in on the company. Robert W. Baird cut their price objective on HCA Healthcare from $450.00 to $442.00 and set a “neutral” rating on the stock in a report on Wednesday, April 15th. Truist Financial set a $413.00 target price on shares of HCA Healthcare in a report on Thursday, June 4th. Cantor Fitzgerald reaffirmed an “overweight” rating on shares of HCA Healthcare in a report on Wednesday, March 4th. TD Cowen reduced their price objective on HCA Healthcare from $500.00 to $431.00 and set a “buy” rating for the company in a research note on Monday. Finally, Wall Street Zen cut shares of HCA Healthcare from a “buy” rating to a “hold” rating in a research note on Saturday, May 2nd. Fifteen analysts have rated the stock with a Buy rating, eight have assigned a Hold rating and one has given a Sell rating to the company’s stock. According to data from MarketBeat.com, HCA Healthcare presently has an average rating of “Moderate Buy” and an average target price of $503.00.

HCA Healthcare Company Profile

HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.